Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,388 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia

NCT02733042

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Pinnacle Oncology Hematology Scottsdale, Arizona, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • Shands Cancer Center University of Florida Gainesville, Florida, United States
View all 66 locations
View Trial Details
Completed

A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies

NCT02352558

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +30 more
Locations
  • Rocky Mountain Cancer Centers Denver, Colorado, United States
  • Indiana University Indianapolis, Indiana, United States
  • West Clinic Germantown, Tennessee, United States
  • Cancer Care Centers of South Texas San Antonio, Texas, United States
View Trial Details
Completed

Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant

NCT02869633

Conditions
Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
View Trial Details
Completed

A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia)

NCT04198415

Conditions
Cancer, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +17 more
Locations
  • Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital /ID# 239524 Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital /ID# 225300 Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital /ID# 240820 Nagoya, Aichi-ken, Japan
  • Toyohashi Municipal Hospital /ID# 227433 Toyohashi, Aichi-ken, Japan
View all 102 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT05338892

Conditions
Chronic Disease, Diffuse Large B-cell Lymphoma, Disease Attributes, +20 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details

Related conditions